z-logo
open-access-imgOpen Access
The SONAR study—is there a future for endothelin receptor antagonists in diabetic kidney disease?
Author(s) -
Avivit Cahn,
Simona Cernea,
Itamar Raz
Publication year - 2019
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2019.09.117
Subject(s) - medicine , kidney disease , diabetes mellitus , disease , endothelin receptor , kidney , endocrinology , receptor
Diabetic kidney disease (DKD) is a clinical diagnosis of chronic kidney disease (CKD) in a patient with diabetes mellitus in the absence of signs or symptoms of other primary causes of kidney damage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom